177 related articles for article (PubMed ID: 20830759)
1. The effects of decorin and HGF-primed vocal fold fibroblasts in vitro and ex vivo in a porcine model of vocal fold scarring.
Krishna P; Regner M; Palko J; Liu F; Abramowitch S; Jiang J; Wells A
Laryngoscope; 2010 Nov; 120(11):2247-57. PubMed ID: 20830759
[TBL] [Abstract][Full Text] [Related]
2. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar.
Krishna P; Rosen CA; Branski RC; Wells A; Hebda PA
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):937-45. PubMed ID: 17141088
[TBL] [Abstract][Full Text] [Related]
3. Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor.
Mizuta M; Hirano S; Ohno S; Kanemaru S; Nakamura T; Ito J
Laryngoscope; 2014 Mar; 124(3):E81-6. PubMed ID: 24115162
[TBL] [Abstract][Full Text] [Related]
4. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model.
Hirano S; Bless DM; Rousseau B; Welham N; Montequin D; Chan RW; Ford CN
Laryngoscope; 2004 Mar; 114(3):548-56. PubMed ID: 15091233
[TBL] [Abstract][Full Text] [Related]
5. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
Hirano S; Bless D; Heisey D; Ford C
Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
[TBL] [Abstract][Full Text] [Related]
6. Cryotherapy has antifibrotic and regenerative effects on human vocal fold fibroblasts.
Gong T; Zhang C; Kang J; Lamb JJ; Jiang JJ
Laryngoscope; 2019 Apr; 129(4):E143-E150. PubMed ID: 30315572
[TBL] [Abstract][Full Text] [Related]
7. Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts.
Kishimoto Y; Hirano S; Suehiro A; Tateya I; Kanemaru S; Nakamura T; Ito J
Ann Otol Rhinol Laryngol; 2009 Aug; 118(8):606-11. PubMed ID: 19746761
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation.
Vyas B; Ishikawa K; Duflo S; Chen X; Thibeault SL
Ann Otol Rhinol Laryngol; 2010 May; 119(5):350-7. PubMed ID: 20524582
[TBL] [Abstract][Full Text] [Related]
9. Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor.
Hirano S; Bless DM; Massey RJ; Hartig GK; Ford CN
Ann Otol Rhinol Laryngol; 2003 Dec; 112(12):1026-33. PubMed ID: 14703105
[TBL] [Abstract][Full Text] [Related]
10. Chronic vocal fold scar restoration with hepatocyte growth factor hydrogel.
Kishimoto Y; Hirano S; Kitani Y; Suehiro A; Umeda H; Tateya I; Kanemaru S; Tabata Y; Ito J
Laryngoscope; 2010 Jan; 120(1):108-13. PubMed ID: 19877197
[TBL] [Abstract][Full Text] [Related]
11. Growth factor therapy for vocal fold scarring in a canine model.
Hirano S; Bless DM; Nagai H; Rousseau B; Welham NV; Montequin DW; Ford CN
Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):777-85. PubMed ID: 15535139
[TBL] [Abstract][Full Text] [Related]
12. Vocal fold fibroblast response to growth factor treatment is age dependent: results from an in vitro study.
Graupp M; Kiesler K; Friedrich G; Ainödhofer H; Gruber HJ; Kieslinger P; Saxena A; Hirano S; Gugatschka M
J Voice; 2014 Jul; 28(4):420-3. PubMed ID: 24495429
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.
Ohno T; Hirano S; Kanemaru S; Yamashita M; Umeda H; Suehiro A; Tamura Y; Nakamura T; Ito J; Tabata Y
Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):762-9. PubMed ID: 17987782
[TBL] [Abstract][Full Text] [Related]
14. Prevention of vocal fold scarring by local application of basic fibroblast growth factor in a rat vocal fold injury model.
Suzuki R; Kawai Y; Tsuji T; Hiwatashi N; Kishimoto Y; Tateya I; Nakamura T; Hirano S
Laryngoscope; 2017 Feb; 127(2):E67-E74. PubMed ID: 27411786
[TBL] [Abstract][Full Text] [Related]
15. Dual growth factor-immobilized bioactive injection material for enhanced treatment of glottal insufficiency.
Choi YH; Ahn HJ; Park MR; Han MJ; Lee JH; Kwon SK
Acta Biomater; 2019 Mar; 86():269-279. PubMed ID: 30599245
[TBL] [Abstract][Full Text] [Related]
16. Towards an in vitro fibrogenesis model of human vocal fold scarring.
Graupp M; Rinner B; Frisch MT; Weiss G; Fuchs J; Sundl M; El-Heliebi A; Moser G; Kamolz LP; Karbiener M; Gugatschka M
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1211-1218. PubMed ID: 29520499
[TBL] [Abstract][Full Text] [Related]
17. Regulation of wound healing by granulocyte-macrophage colony-stimulating factor after vocal fold injury.
Lim JY; Choi BH; Lee S; Jang YH; Choi JS; Kim YM
PLoS One; 2013; 8(1):e54256. PubMed ID: 23372696
[TBL] [Abstract][Full Text] [Related]
18. Effects of basic fibroblast growth factor on rat vocal fold fibroblasts.
Suehiro A; Hirano S; Kishimoto Y; Tateya I; Rousseau B; Ito J
Ann Otol Rhinol Laryngol; 2010 Oct; 119(10):690-6. PubMed ID: 21049855
[TBL] [Abstract][Full Text] [Related]
19. The Antiproliferative and Antifibrotic Effects of Cisplatin on Primary Human Vocal Fold Fibroblasts.
Xu H; Wang Q; Fan GK
ORL J Otorhinolaryngol Relat Spec; 2020; 82(4):188-200. PubMed ID: 32268330
[TBL] [Abstract][Full Text] [Related]
20. A rat excised larynx model of vocal fold scar.
Welham NV; Montequin DW; Tateya I; Tateya T; Choi SH; Bless DM
J Speech Lang Hear Res; 2009 Aug; 52(4):1008-20. PubMed ID: 19641079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
